VEGFA and cancer: Moreover, VEGF-A maintains the quiescent endothelial cells of healthy vessels, and, therefore, antiangiogenic therapies cause grave side effects, including bleeding and disturbed wound healing, that can lead to life-threatening conditions in cancer patients [30].